1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Neuromodulation Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Neuromodulation Devices Market, Germany
3.1 Neuromodulation Devices Market, Germany, Revenue ($m), 2018-2033
3.1.1 Implantable Neuromodulation Devices Market, Germany, Revenue ($m), by Segment, 2018-2033
3.2 Neuromodulation Devices Market, Germany, Volume (Units), 2018-2033
3.2.1 Implantable Neuromodulation Devices Market, Germany, Volume (Units), by Segment, 2018-2033
3.3 Neuromodulation Devices Market, Germany, Average Price ($), 2018-2033
3.4 Neuromodulation Devices Market, Germany, Company Share by Revenue ($m), 2025
4 Overview of Key Companies in Germany, Neuromodulation Devices Market
4.1 Medtronic Plc
4.1.1 Company Overview
4.2 Boston Scientific Corp
4.2.1 Company Overview
4.3 Abbott Laboratories
4.3.1 Company Overview
4.4 LivaNova Plc
4.4.1 Company Overview
4.5 Nevro Corp
4.5.1 Company Overview
4.6 Enterra Medical Inc
4.6.1 Company Overview
4.7 Axonics Inc
4.7.1 Company Overview
4.8 B. Braun Melsungen AG
4.8.1 Company Overview
4.9 Bioness Inc
4.9.1 Company Overview
4.10 Xavant Technology (Pty) Ltd
4.10.1 Company Overview
6 Recent Developments
6.1 Corporate Communications
6.1.1 Nov 11, 2025: Novel Technique Enhances Brain-State Detection
6.1.2 Sep 08, 2025: Changes To The Executive Board Of Carl Zeiss AG
6.1.3 Mar 25, 2025: CorTec Names Frank Desiere as Chief Executive Officer
6.2 Product News
6.2.1 Oct 31, 2025: European Investment Bank Supports German MedTech with €20 Million for PRECISIS
6.2.2 Oct 16, 2025: First Brain-Computer Interface Implantation for Paralysis in Europe
6.2.3 Sep 10, 2025: Neurocare Group's Apollo TMS Therapy Devices Granted FDA Clearance for Treating Adolescent Depression
6.2.4 Sep 08, 2025: Onward Medical Receives CE Mark for Arc-Ex, Enabling Commercial Launch in Europe
6.3 Strategy And Business Planning
6.3.1 Nov 04, 2025: Zeiss Opens New Quality Excellence Center in Connecticut
6.3.2 Oct 31, 2025: European Investment Bank Supports German MedTech with €20 Million for PRECISIS
7 Appendix
7.1 Research Methodology
7.1.1 Coverage
7.1.2 Secondary Research
7.1.3 Primary Research
7.1.4 Market Modeling and Forecasting
7.1.5 Company Share Analysis
7.1.6 Benchmarking
7.2 the analyst Consulting
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
Table 1: Neuromodulation Devices Market, Germany, Revenue ($m), USD Constant, 2018-2033
Table 2: Implantable Neuromodulation Devices Market, Germany, Revenue ($m), USD Constant, 2018-2033
Table 3: Neuromodulation Devices Market, Germany, Volume (Units), 2018-2033
Table 4: Implantable Neuromodulation Devices Market, Germany, Volume (Units), 2018-2033
Table 5: Neuromodulation Devices Market, Germany, Average Price ($), 2018-2033
Table 6: Neuromodulation Devices Market, Germany, Company Share by Revenue ($m), 2025
Table 7: Neuromodulation Devices Market Pipeline Products
Table 8: Total Number of Primary Research Participants, Neurology Devices Market, by Country
List of Figures
Figure 1: Neuromodulation Devices Market, Germany, Revenue ($m), USD Constant, 2018-2033
Figure 2: Implantable Neuromodulation Devices Market, Germany, Revenue ($m), USD Constant, 2018-2033
Figure 3: Neuromodulation Devices Market, Germany, Volume (Units), 2018-2033
Figure 4: Implantable Neuromodulation Devices Market, Germany, Volume (Units), 2018-2033
Figure 5: Neuromodulation Devices Market, Germany, Company Share (%), 2025
